Kawasaki syndrome and factors associated with coronary artery abnormalities in California

Pediatric Infectious Disease Journal

Volumn 31, Issue 9, 2012, Pages 894-898

  Callinan, Laura S ^a   Tabnak, Farzaneh ^b   Holman, Robert C ^a   Maddox, Ryan A ^a   Kim, Janice J ^b   Schonberger, Lawrence B ^a   Vugia, Duc J ^b   Belay, Ermias D ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b Division of Communicable Disease Control   (United States)

Author keywords

California; children; coronary artery abnormalities; epidemiology; Kawasaki syndrome

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CHILD; CORONARY ARTERY ABNORMALITY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SURVEILLANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK FACTOR; SCHOOL CHILD; UNITED STATES;

EID: 85027952859     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31825c4d7c     Document Type: Article

References (46)

1. Newburger JW, Takahashi M, Gerber MA, et al.; Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004;114:1708-1733.
2. Newburger JW, Fulton DR. Kawasaki disease. Curr Opin Pediatr. 2004;16:508-514.
3. Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis. 2005;9:185-194.
4. Burns JC, Glodé MP. Kawasaki syndrome. Lancet. 2004;364:533-544.
5. Belay ED, Maddox RA, Holman RC, et al. Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003. Pediatr Infect Dis J. 2006;25:245-249.
6. Manlhiot C, Yeung RS, Clarizia NA, et al. Kawasaki disease at the extremes of the age spectrum. Pediatrics. 2009;124:e410-e415.
7. Bronstein DE, Dille AN, Austin JP, et al. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr Infect Dis J. 2000;19:1087-1091.
8. Ichida F, Fatica NS, O'Loughlin JE, et al. Epidemiologic aspects of Kawasaki disease in a Manhattan hospital. Pediatrics. 1989;84:235-241.
9. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome in Hawaii. Pediatr Infect Dis J. 2005;24:429-433.
10. Khan AS, Holman RC, Clarke MJ, et al. Kawasaki syndrome surveillance, United States, 1991-1993. In: , Kato H, ed. Kawasaki Disease. Amsterdam: Elsevier Science; 1995:80-84.
11. Holman RC, Curns AT, Belay ED, et al. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics. 2003;112(3, pt 1): 495-501.
12. Bell DM, Morens DM, Holman RC, et al. Kawasaki syndrome in the United States 1976 to 1980. Am J Dis Child. 1983;137:211-214.
13. Dean AG, Melish ME, Hicks R, et al. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr. 1982;100:552-557.
14. Chang RK. Epidemiologic characteristics of children hospitalized for Kawasaki disease in California. Pediatr Infect Dis J. 2002;21:1150-1155.
15. Tremoulet AH, Devera G, Best BM, et al. Increased incidence and severity of Kawasaki disease among Filipino-Americans in San Diego county. Pediatr Infect Dis J. 2011;30:909-911.
16. Sung RY, Ng YM, Choi KC, et al.; Hong Kong Kawasaki Disease Study Group. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease. Pediatr Infect Dis J. 2006;25:521-525.
17. American Academy of Pediatrics. Kawasaki Disease. In: Pickering LK, ed. Red Book: 2009 Report of the Committee on Infectious Diseases. 28th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2009:413-418.
18. Son MB, Gauvreau K, Ma L, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009;124:1-8.
19. Rowley AH. Incomplete (atypical) Kawasaki disease. Pediatr Infect Dis J. 2002;21:563-565.
20. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J Epidemiol. 2008;18:167-172.
21. Holman RC, Belay ED, Christensen KY, et al. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J. 2010;29:483-488.
22. Belay ED, Holman RC, Clarke MJ, et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatr Infect Dis J. 2000;19:828-832.
23. Gibbons RV, Parashar UD, Holman RC, et al. An evaluation of hospitalizations for Kawasaki syndrome in Georgia. Arch Pediatr Adolesc Med. 2002;156:492-496.
24. Holman RC, Shahriari A, Effler PV, et al. Kawasaki syndrome hospitalizations among children in Hawaii and Connecticut. Arch Pediatr Adolesc Med. 2000;154:804-808.
25. Davis RL, Waller PL, Mueller BA, et al. Kawasaki syndrome in Washington State. Race-specific incidence rates and residential proximity to water. Arch Pediatr Adolesc Med. 1995;149:66-69.
26. Holman RC, Christensen KY, Belay ED, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J. 2010;69:194-197.
27. Barnes JS, Bennett CE. The Asian Population: 2000 Census 2000 Brief. Washington, DC: U.S. Census Bureau; 2002.
28. State of California Health and Human Services Agency, Department of Public Health. Title 17, California Code of Regulations (CCR) 2500, 2593, 2641.5-2643.20, and 2800-2812 Reportable Diseases and Conditions. 2009.
29. California Department of Public Health. Kawasaki Syndrome Case Report 2007. Available at: http://www.cdph.ca.gov/pubsforms/forms/CtrldForms/cdph8468. pdf. Accessed August 17, 2011.
30. US Centers for Disease Control and Prevention. Kawasaki Syndrome Case Report 2010. Available at: http://www.cdc.gov/kawasaki/docs/ks-case-report- print.pdf. Accessed August 17, 2011.
31. Diagnostic guidelines for Kawasaki disease. Circulation. 2001;103:335-336.
32. Kleinbaum DG, Klein M. Logistic Regression: A Self-Learning Text. 2nd ed. New York, NY: Springer-Verlag New York, Inc.; 2002.
33. California Department of Finance: Reports and Research Papers 2011. Available at: http://www.dof.ca.gov/research/demographic/reports/view.php #objCollapsiblePanelEstimatesAnchor. Accessed November 7, 2011.
34. United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). Bridged-Race Population Estimates, United States July 1st resident population by state, county, age, sex, bridged-race, and Hispanic origin, compiled from 1990-1999 bridged-race intercensal population estimates and 2000-2009 (Vintage 2009) bridged-race postcensal population estimates, on CDC WONDER On-line Database. Available at: http://wonder.cdc.gov/bridged-race-v2009. html. Accessed July 11, 2011.
35. Abuhammour WM, Hasan RA, Eljamal A, et al. Kawasaki disease hospitalizations in a predominantly African-American population. Clin Pediatr (Phila). 2005;44:721-725.
36. Tseng CF, Fu YC, Fu LS, et al. Clinical spectrum of Kawasaki disease in infants. Zhonghua Yi Xue Za Zhi (Taipei). 2001;64:168-173.
37. Joffe A, Kabani A, Jadavji T. Atypical and complicated Kawasaki disease in infants. Do we need criteria? West J Med. 1995;162:322-327.
38. Sabharwal T, Manlhiot C, Benseler SM, et al. Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol. 2009;104:1743-1747.
39. de Zorzi A, Colan SD, Gauvreau K, et al. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr. 1998;133:254-258.
40. Muta H, Ishii M, Egami K, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J Pediatr. 2004;144:496-499.
41. Zhang T, Yanagawa H, Oki I, et al. Factors relating to the cardiac sequelae of Kawasaki disease one month after initial onset. Acta Paediatr. 2002;91: 517-520.
42. Tse SM, Silverman ED, McCrindle BW, et al. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr. 2002;140:450-455.
43. Salo E. Kawasaki disease in Finland in 1982-1992. Scand J Infect Dis. 1993;25:497-502.
44. Fong NC, Hui YW, Li CK, et al. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness. Pediatr Cardiol. 2004;25:31-34.
45. Muta H, Ishii M, Iemura M, et al. Effect of revision of Japanese diagnostic criterion for fever in Kawasaki disease on treatment and cardiovascular outcome. Circ J. 2007;71:1791-1793.
46. Nomura Y, Masuda K, Yoshinaga M, et al. Patients diagnosed with Kawasaki disease before the fifth day of illness have a higher risk of coronary artery aneurysm. Pediatr Int. 2002;44:353-357.